Blurring the line: measuring how astigmatism impacts vision after cataract surgery

NCT ID NCT06784063

First seen Jul 13, 2026 · Last updated Jul 14, 2026 · Updated 1 time

Summary

This study looks at how residual astigmatism affects vision in people who have already received the Clareon Vivity extended vision intraocular lens (IOL) during cataract surgery. Researchers will temporarily induce astigmatism using trial lenses and measure changes in distance, intermediate, and near visual acuity. The goal is to quantify the impact of astigmatism on visual performance with this specific IOL.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Clareon Vivity Extended Vision Intraocular Lens (IOL)
What this could lead to
If successful, this study could help eye surgeons understand how much astigmatism can be left uncorrected without harming visual performance after cataract surgery with this lens.
What could go wrong
This is a small, observational study with only 40 participants. It measures vision under artificial astigmatism in a lab setting, which may not reflect real-world conditions or long-term outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ASTIGMATISM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Berkeley Eye Center

    Sugar Land, Texas, 77478, United States

  • Grosinger, Spigelman & Grey Eye Surgeons, P.C

    Bloomfield Hills, Michigan, 48302, United States

  • Key-Whitman Eye Center

    Dallas, Texas, 75243, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.